Table 1. Patient characteristics.
| Factor | All (n = 587) | LGE Absent (n = 312) | LGE Present (n = 275) | p-value |
|---|---|---|---|---|
| Characteristics | ||||
| Age (years) | 48±16 | 47±15 | 49±15 | 0.149 |
| Gender (females) | 242 (41) | 159 (51) | 83 (30) | <0.001* |
| BMI (kg/m2) | 27.7±6.2 | 27.4±6.1 | 27.9±6.0 | 0.348 |
| Medical History | ||||
| Hypertension | 153 (26) | 81 (26) | 72 (29) | 0.907 |
| Smoking | 72 (12) | 36 (12) | 36 (13) | 0.988 |
| Diabetes Mellitus | 53 (9) | 32 (10) | 21 (8) | 0.441 |
| Acute Presentation of Symptoms (<2 weeks) | 323 (55) | 161 (50) | 162 (59) | 0.081 |
| Chest Pain | 104 (17) | 49 (16) | 46 (17) | 0.738 |
| Dyspnoea | 197 (32) | 85 (27) | 110 (40) | 0.001* |
| Arrhythmia | 117 (19) | 75 (24) | 42 (15) | 0.009* |
| Palpitations | 110 (18) | 69 (22) | 39 (14) | 0.014* |
| Syncope | 50 (8) | 32 (10) | 15 (5) | 0.034* |
| Recent Infection | 150 (35) | 68 (22) | 79 (29) | 0.057 |
| Medication | ||||
| ASA | 165 (29) | 77 (25) | 88 (32) | 0.061 |
| ACE Inhibitors | 208 (36) | 100 (33) | 108 (39) | 0.057 |
| Beta Blockers | 236 (41) | 102 (33) | 134 (50) | <0.001* |
| Diuretics | 122 (21) | 47 (16) | 75 (28) | <0.001* |
| Statins | 123 (21) | 53 (17) | 70 (26) | 0.011* |
| ARB | 15 (3) | 7 (2) | 8 (3) | 0.794 |
Mean±SD or n (%) are shown for the entire population and dichomotomized by the absence or presence of LGE. ACE: Angiotensin-converting enzyme inhibitors, ARB: Angiotensin II Receptor Blockers, ASA: Acetylsalicylic acid, BMI: Body Mass Index, LGE: Late Gadolinium Enhancement.
*p<0.05 denotes a significant difference between groups.